January 11, 2022 Comments Off on New patent for Novartis drug KISQALI Posted in: Patent Added Annual Drug Patent Expirations for KISQALI Kisqali is a drug marketed by Novartis and is included in two NDAs. It is available from one supplier. There are eight patents protecting…
The post New patent for Novartis drug KISQALI appeared first on DrugPa…
January 11, 2022 Comments Off on Drug Patent Expirations for the Week of January 9, 2022 Posted in: Uncategorized
ALPHAGAN P (brimonidine tartrate) Allergan Patent: 9,295,641 Expiration: Jan 10, 2022 See More … For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact [email protected]…
The post Drug…
